Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system
about
Urine-derived induced pluripotent stem cells as a modeling tool to study rare human diseasesDirected differentiation of human iPSC into insulin producing cells is improved by induced expression of PDX1 and NKX6.1 factors in IPC progenitorsSOX2 and SOX2-MYC Reprogramming Process of Fibroblasts to the Neural Stem Cells Compromised by Senescence.Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells.Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.Impact of Different Promoters on Episomal Vectors Harbouring Characteristic Motifs of Matrix Attachment Regions.Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.Advances in Non-Viral DNA Vectors for Gene Therapy.iPSC-based drug screening for Huntington's disease.Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.Transient Tcf3 Gene Repression by TALE-Transcription Factor Targeting.The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System.Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions.Nonintegrating Human Somatic Cell Reprogramming Methods.A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis.Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome.Application of induced pluripotency in cancer studies.
P2860
Q28073204-2684A492-2CED-47F3-BEAB-A3603B1487C6Q28817053-53DDE20A-654A-443E-A3A3-B70BF1406227Q35831780-279ADAD4-E19F-46C6-857F-1C2FCDF19831Q36120100-4C27967F-D0B8-474E-8465-5B5707228177Q36781413-D84AEF38-5E8A-49A9-9E33-9D472AA33E8AQ36937744-933AA147-2BEB-4FA8-864C-2E1FD14D2927Q37631694-CF3AFD67-1E3E-4E85-A3E3-2CF250F22EE8Q37676243-A94AD1B1-A08C-4878-BF83-C691B8D41148Q38597179-F9538C0A-730D-4D14-B5B3-8E05F4CF4037Q38672652-E8C5E242-C87B-4CA5-91BF-131F0E220E6BQ38758515-DCB576B5-1932-40B6-82CB-78EE7551C432Q40295198-451D38B6-E481-4B74-8722-84CA0873DD72Q47212273-5D2D99B0-CC81-4529-A7B5-5CCCD9614509Q47598499-C788BFEE-9663-4580-AA0F-DF38901B543AQ47830673-D4AF6C44-2ED6-4E1E-86FD-C2E16E1E232AQ48342092-BA630461-461D-49B2-B032-0E3BE77E430EQ53682453-08047758-DB71-4A67-9642-9A10B7503CC4
P2860
Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Generation of human iPSCs from ...... episomal reprogramming system
@ast
Generation of human iPSCs from ...... episomal reprogramming system
@en
type
label
Generation of human iPSCs from ...... episomal reprogramming system
@ast
Generation of human iPSCs from ...... episomal reprogramming system
@en
prefLabel
Generation of human iPSCs from ...... episomal reprogramming system
@ast
Generation of human iPSCs from ...... episomal reprogramming system
@en
P2093
P2860
P50
P1476
Generation of human iPSCs from ...... episomal reprogramming system
@en
P2093
Anna M Drozd
Maciej P Walczak
Sylwester Piaskowski
P2860
P2888
P356
10.1186/S13287-015-0112-3
P577
2015-06-19T00:00:00Z
P5875
P6179
1027843339